Cargando…
Noninvasive prenatal diagnosis based on cell‐free DNA for tuberous sclerosis: A pilot study
BACKGROUND: Noninvasive prenatal diagnosis (NIPD) based on cell‐free DNA (cfDNA) has been introduced into the clinical application for some monogenic disorders but not for tuberous sclerosis (TSC) yet, which is an autosomal dominant disease caused by various variations in TSC1 or TSC2 gene. We aimed...
Autores principales: | Yang, Xiao‐Yan, Meng, Yan, Wang, Yang‐Yang, Lu, Yan‐Ping, Wang, Qiu‐Hong, You, Yan‐Qin, Xie, Xiao‐Xiao, Bai, Ling, Fang, Nan, Zou, Li‐Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266619/ https://www.ncbi.nlm.nih.gov/pubmed/35429229 http://dx.doi.org/10.1002/mgg3.1952 |
Ejemplares similares
-
Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin
por: Lu, Qian, et al.
Publicado: (2022) -
Postnatal Cytomegalovirus Infection May Increase the Susceptibility of Tuberous Sclerosis Complex to Autism Spectrum Disorders
por: Yang, Xiao-Yan, et al.
Publicado: (2022) -
Vigabatrin-associated brain abnormalities on MRI in tuberous
sclerosis complex patients with infantile spasms: are they
preventable?
por: Wan, Lin, et al.
Publicado: (2022) -
Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex
por: Lu, Qian, et al.
Publicado: (2020) -
Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
por: Wang, Dong-Dong, et al.
Publicado: (2020)